PRTK

Paratek Pharmaceuticals, Inc.
PRTK

Overview Fund Activity
Delisted

PRTK was delisted on the 20th of September, 2023.

Back to rankings

63 hedge funds and large institutions have $59M invested in Paratek Pharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-13
Holders Change %
-17.11%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
18
Reduced
22
Closed
18
Calls
$172K
Puts
$34K
Net Calls
+$138K
Net Calls Change
+$47K

Top Buyers

1
NAM
Nexpoint Asset Management
Texas
$6.34M
2
CG
Carlyle Group
District of Columbia
$2.62M
3
JGC
J. Goldman & Co
New York
$2.33M
4
EP
Eversept Partners
New York
$1.62M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$935K

Top Sellers

1
ACM
AIGH Capital Management
Maryland
$6.79M
2
Millennium Management
Millennium Management
New York
$182K
3
WVP
Worth Venture Partners
New Jersey
$1.67M
4
TMC
Trellus Management Company
Florida
$323K
5
Citadel Advisors
Citadel Advisors
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BNP Paribas Financial Markets
76
BNP Paribas Financial Markets
France
– -$24K -12,817 Closed
TSS
77
Two Sigma Securities
New York
– -$23.5K -12,575 Closed
QT
78
Quantbot Technologies
New York
– -$12.3K -6,600 Closed
SAM
79
Silverback Asset Management
North Carolina
– -$1.84K -986 Closed
KFI
80
Key Financial Inc
Pennsylvania
– -$1.22K -475 Closed
Citigroup
81
Citigroup
New York
– -$4 -2 Closed
1 2 3
4